Ålgars A - Search Results

1

EGFR gene copy number predicts response to anti-EGFR treatment in RAS wild type and RAS/BRAF/PIK3CA wild type metastatic colorectal cancer.

Ålgars A, Sundström J, Lintunen M, Jokilehto T, Kytölä S, Kaare M, Vainionpää R, Orpana A, Österlund P, Ristimäki A, Carpen O, Ristamäki R. Ålgars A, et al. Int J Cancer. 2017 Feb 15;140(4):922-929. doi: 10.1002/ijc.30507. Epub 2016 Nov 23. Int J Cancer. 2017. PMID: 27879995

2

Response to chemotherapy (irinotecan plus 5-fluorouracil) in colorectal carcinoma can be predicted by tumour DNA content.

Bendardaf R, Lamlum H, Ristamäki R, Algars A, Collan Y, Pyrhönen S. Bendardaf R, et al. Among authors: algars a. Oncology. 2004;66(1):46-52. doi: 10.1159/000076334. Oncology. 2004. PMID: 15031598

3

Nuclear size as prognostic determinant in stage II and stage III colorectal adenocarcinoma.

Buhmeida A, Algars A, Ristamäki R, Collan Y, Syrjänen K, Pyrhönen S. Buhmeida A, et al. Among authors: algars a. Anticancer Res. 2006 Jan-Feb;26(1B):455-62. Anticancer Res. 2006. PMID: 16739305 Free article.

4

E-cadherin expression pattern in primary colorectal carcinomas and their metastases reflects disease outcome.

Elzagheid A, Algars A, Bendardaf R, Lamlum H, Ristamaki R, Collan Y, Syrjanen K, Pyrhonen S. Elzagheid A, et al. Among authors: algars a. World J Gastroenterol. 2006 Jul 21;12(27):4304-9. doi: 10.3748/wjg.v12.i27.4304. World J Gastroenterol. 2006. PMID: 16865770 Free PMC article.

5

Comparison of CD44 expression in primary tumours and metastases of colorectal cancer.

Bendardaf R, Algars A, Elzagheid A, Korkeila E, Ristamäki R, Lamlum H, Collan Y, Syrjänen K, Pyrhönen S. Bendardaf R, et al. Among authors: algars a. Oncol Rep. 2006 Oct;16(4):741-6. Oncol Rep. 2006. PMID: 16969488

6

DNA image cytometry is a useful adjunct tool in the prediction of disease outcome in patients with stage II and stage III colorectal cancer.

Buhmeida A, Algars A, Ristamäki R, Collan Y, Syrjänen K, Pyrhönen S. Buhmeida A, et al. Among authors: algars a. Oncology. 2006;70(6):427-37. doi: 10.1159/000098556. Epub 2007 Jan 12. Oncology. 2006. PMID: 17220640

7

Thymidylate synthase expression in primary colorectal tumours is correlated with its expression in metastases.

Bendardaf R, Elzagheid A, Lamlum H, Algars A, Korkeila E, Ristamäki R, Collan Y, Syrjänen K, Pyrhönen S. Bendardaf R, et al. Among authors: algars a. Scand J Gastroenterol. 2007 Apr;42(4):471-6. doi: 10.1080/00365520600960120. Scand J Gastroenterol. 2007. PMID: 17454857

8

EGFR gene copy number assessment from areas with highest EGFR expression predicts response to anti-EGFR therapy in colorectal cancer.

Ålgars A, Lintunen M, Carpén O, Ristamäki R, Sundström J. Ålgars A, et al. Br J Cancer. 2011 Jul 12;105(2):255-62. doi: 10.1038/bjc.2011.223. Epub 2011 Jun 21. Br J Cancer. 2011. PMID: 21694725 Free PMC article.

9

Type and location of tumor-infiltrating macrophages and lymphatic vessels predict survival of colorectal cancer patients.

Algars A, Irjala H, Vaittinen S, Huhtinen H, Sundström J, Salmi M, Ristamäki R, Jalkanen S. Algars A, et al. Int J Cancer. 2012 Aug 15;131(4):864-73. doi: 10.1002/ijc.26457. Epub 2011 Nov 8. Int J Cancer. 2012. PMID: 21952788

10

Heterogeneous EGFR gene copy number increase is common in colorectal cancer and defines response to anti-EGFR therapy.

Ålgars A, Avoranta T, Österlund P, Lintunen M, Sundström J, Jokilehto T, Ristimäki A, Ristamäki R, Carpén O. Ålgars A, et al. PLoS One. 2014 Jun 18;9(6):e99590. doi: 10.1371/journal.pone.0099590. eCollection 2014. PLoS One. 2014. PMID: 24940619 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Search Page

Filters